A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 


Dr. LilyHechtman, MD,FRCP
Professor of Psychiatry and Pediatrics


Psychiatry
Attention deficit/hyperactivity disorder


McGill University Health Centre, Montreal Children's Hospital
4018 Ste-Catherine Street West
Montreal
Quebec
H3Z 1P2
514-412-4449
514-412-4337

lily.hechtmans@mcgill.ca
514-412-4400, ext. 23785



Dr. Hechtman is a professor of psychiatry and pediatrics at McGill University and Director of Research, Division of Child Psychiatry. She is a child psychiatrist and an internationally recognized researcher in ADHD. Dr. Hechtman’s research has focused on long-term (15-year) prospective studies of children with ADHD followed into adolescence and adulthood. Outcomes and factors that influence these outcomes are summarized in Weiss, G, Hechtman, L: Hyperactive Children Grown Up, second edition, Guilford Press. Recently, Dr. Hechtman has focused on the diagnosis and treatment of adults with ADHD. This work is outlined in Weiss, M, Hechtman, L, Weiss, G: ADHD in Adulthood – A Guide to Current Theory, Diagnosis, and Treatment. The John Hopkins Press. Drs. Hechtman and Abikoff conducted the first controlled multimodal treatment study on children with ADHD. This study set the stage for the multisite multimodal treatment study (The MTA). Dr. Hechtman heads one of the sites for the MTA. Dr. Hechtman’s honours include: • Children and Adults with Attention Deficit Disorder CHADD” Hall of Fame. CHADD considers the Hall of Fame to be its highest recognition. This award is reserved for outstanding individuals for their contributions advancing the science of ADHD and/or to advancing their educational or legislative/advocacy mission of CHADD. • American Academy of Child and Adolescent Psychiatry, Elaine Schlosser Lewis Award for research on Attention Deficit Disorder. • American Academy of Child and Adolescent Psychiatry Pilot Project Award for Attention Deficit Disorder (Dr. Jeanie Tse—resident, Dr. Lily Hechtman—mentor). • Canadian Academy of Child and Adolescent Psychiatry, Paul D. Steinhauer Advocacy Award in testament for work as an exceptional advocate for children, adolescents, and their families at the regional, national, and international level. • Canadian Academy of Child and Adolescent Psychiatry Honorary Member Award for an academic career with outstanding contributions in service, teaching, and research at the regional, national, and international level. • Canadian Academy of Child and Adolescent Psychiatry Dalhousie Award for best presentation by a full member on “Recent follow-up findings of the Multisite multimodal treatment study of children with ADHD (MTA).” In summary, Dr. Hechtman combines a rigorous research background with extensive clinical expertise and experience.


American Boards of Psychiatry and Neurology
Quebec College of Physicians and Surgeons Certification in Psychiatry

Certification as Fellow of Royal College of Physicians and Surgeons in Psychiatry, Canada (FRCP (C))


Quebec Psychiatric Association
Canadian Academy of Child Psychiatry

American Academy of Child and Adolescent Psychiatry



Cumyn L, French L, Hechtman L. Comorbidity in adults with attention-deficit/hyperactivity disorder. Canadian Journal of Psychiatry. 2009;54(10):673-683.

Cherkasova M, Hechtman L. Functional neuroimaging in attention-deficit/hyperactivity disorder: beyond the frontostriatal circuitry. Canadian Journal of Psychiatry. 2009;54(10):651-664.

Cumyn L, French L, Hechtman L. ADHD and comorbid depression. Current Attention Disorders Reports. 2009;1(2):53-59.

Hechtman L. Effects of treatment on the overall functioning of children with ADHD. Journal of the Canadian Academy of Child and Adolescent Psychiatry. 2009;18(2) Suppl:11-16.

Kolar D, Keller A, Golfinopoulos M, Cumyn L, Syer C, Hechtman L. Treatment of adult attention-deficit/disorder. Neuropsychiatric Diseases and Treatment. 2008;4(2):389-403.

Weiss M, Hechtman L, Turgay A, Jain U, Quinn D, Ahmed TS, Yates T, Reiz JL, Donnelly GA, Harsanyi Z, Darke AC. Once-daily Multilayer-Release Methylphenidate in a double-blind, crossover comparison to Immediate-Release Methylphenidate in children with ADHD. Journal of Child and Adolescent Psychopharmacology. 2007;17(5):675-688.Psychopharmacology, 17(5):675-688, 2007.

Hechtman L, Etcovitch J, Arnold LE, Abikoff H, Newcorn J, Hoza B, Hinshaw S, Kraemer H, Wells K, Conners K, Elliott G, Greenhill L, Jensen P, March J, Molina B, Pelham W, Severe J, Swanson J, Vitiello B, Wigal T. Does multimodal treatment decrease other diagnoses and impairment in children with ADHD? Clinical Neuroscience Research. 2005;5:273-282.

Eakin L, Minde K, Hechtman L, Ochs E, Bouffard R, Greenfield B, Looper K. The marital and family functioning of adults with ADHD. Journal of Attention Disorders. 2004;9:1-10.

Hechtman L, Abikoff H, Klein RG, Greenfield B, Etcovitch J, Cousins L, Fleiss K, Weiss M, Pollack S. Children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment: impact on parental practices. J Am Acad Child Adolesc Psychiatry. 2004 Jul;43(7):830-8.

Hechtman L, Abikoff H, Klein RG, Greenfield B, Etcovitch J, Cousins L, Fleiss K, Weiss M, Pollack S. Children with ADHD treated with long-term Methylphenidate and multimodal psychosocial treatment: impact on parental practices. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43(7):830-838.